Biologics Manufacturing Technology
Avid Bioservices leverages advanced technologies and state-of-the-art instrumentation to support the development, characterization, and CGMP manufacturing of complex biologics. Our technology platforms are designed to enhance process understanding, ensure product quality, and enable confident progression from early development through commercial supply.
Value
Technology That Enables Control, Consistency, and Scale
Robust technology platforms and modern instrumentation are critical to delivering consistent, high-quality biologics.
Avid integrates advanced upstream, downstream, and
analytical technologies across development and manufacturing to support data-driven decision-making, process optimization, and regulatory alignment. Our investments in automation, single-use systems, and analytical characterization enable disciplined execution at every stage of the product lifecycle.

Overview
Technology & Instrumentation
Downstream Processing Technologies
Modern purification and filtration technologies designed to deliver robust clearance, high yield, and consistent product quality.
Automation and Digital Systems
Process automation, electronic systems, and data integrity controls that enhance operational efficiency, traceability, and regulatory compliance.
Technology Support
One Technology Backbone Supporting
Multiple Programs and Modalities
WHY US
Why Avid for Technology and Instrumentation
Modern single-use and scalable manufacturing platforms
Advanced analytical instrumentation supporting deep product understanding
Integrated automation and digital systems aligned with CGMP requirements
Technology investments that support lifecycle progression and comparability
U.S.-based facilities with aligned systems across development and manufacturing
Technology Designed to Support
Confident Program Advancement
Whether advancing early-stage development or supporting commercial supply, Avid
Bioservices provides the technology, instrumentation, and operational discipline
required to deliver consistent results and regulatory confidence.